RecruitingNCT06373822

New Perspectives in Adenomyosis Pathogenesis With Epigenetic Analysis and miRNAs


Sponsor

Université Catholique de Louvain

Enrollment

50 participants

Start Date

Mar 21, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Objectives: To identify differentially expressed miRNAs in the blood of adenomyosis patients in view to develop new diagnostic methods Hypotheses Circulating miRNAs may be abnormally expressed in patients suffering from adenomyosis and could be used to diagnose the disease Study Design Blood samples will be collected from healthy subjects and adenomyosis patients and miRNAs will be isolated and analyzed to detect potential differences.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria2

  • Age ≥ 18 years
  • Pre-menopausal

Exclusion Criteria3

  • HIV or Hepatitis-positive
  • having participated in another clinical study in the 12 months prior to recruitment
  • presenting symptoms of endometriosis

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCirculating-mirna

A single blood sample (1 tube of 10 ml) on the day of the patient's visit to the service de Gynécologie of the CUSL.


Locations(1)

CUSL

Brussels, Woluwe-Saint-Lambert, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06373822


Related Trials